Palvella Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Palvella Therapeutics Inc
CIK #0001583648, 0001742961
EDGAR Form CIK 2011 - 2026
10-K [0001583648]
10-Q [0001583648]
3 [0001583648]
4 [0001583648]
8-K [0001583648]
D [0001583648]
SC 13D [0001583648]
SC 13G [0001583648]
D [0001742961]
Form 13D/13G Filer Form 13D/13G Subject Filed
First Light Asset Management LLC Palvella Therapeutics Inc [2026-02-17]
Frazier Life Sciences Public Fund LP Palvella Therapeutics Inc [2025-01-08]
Kaupinen WES Palvella Therapeutics Inc [2024-12-20]
Suvretta Capital Management LLC Palvella Therapeutics Inc [2024-12-20]
Samsara Biocapital LP Palvella Therapeutics Inc [2024-12-20]
Dellora Investments LP Pieris Pharmaceuticals Inc [2024-08-07]
ADAR1 Capital Management LLC Pieris Pharmaceuticals Inc [2024-08-01]
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17]
Biotechnology Value Fund L P Pieris Pharmaceuticals Inc [2024-05-17]
Checkpoint Capital LP Pieris Pharmaceuticals Inc [2023-06-12]
View All
Form 3/4/5 Subject 2011 - 2026
Palvella Therapeutics Inc
Pauls Matthew
Goin Kathleen
Korenberg Matthew E
Davis Todd C
Heron Elaine J
Doux John
Kiritsy Christopher P
Wessel Tadd S
Jenkins George M
Kline Ashley Hartmann
Martini Jeffrey S
Kaupinen Wes
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Dellora Investments LP
Geraghty James A
ADAR1 Partners LP
ADAR1 Capital Management LLC
Barbier Ann
Said Maya R
Sherman Matthew L
Kiener Peter A
Richman Michael
Bures Thomas
Kaufmann Hitto
Mousa Ahmed
Yoder Stephen S
Olwill Shane
Demuth Tim
Aquilo Capital Management LLC
Bizzari Jean-Pierre
Reine Allan
Matis Louis
Prelack Steven
OrbiMed Advisors LLC
OrbiMed Capital GP III LLC
Adams Julian
Isaly Samuel D
Khuong Chau Quang
Thibault Lance E
Knopf Claude
Deptula-Hicks Darlene M
Takke Christina
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Palvella Therapeutics Inc PVLA
Common Stock
2026-03-18 Option exercise 2,148 $9.08 19,504
Palvella Therapeutics Inc PVLA
Common Stock
2026-03-18 Sell 1,730 $118.37 204,780
Palvella Therapeutics Inc PVLA
Common Stock
2026-03-18 Sell 304 $119.08 36,200
Palvella Therapeutics Inc PVLA
Common Stock
2026-03-18 Option exercise 2,154 $7.14 15,380
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 2,148 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 2,154 $0.00
Palvella Therapeutics Inc PVLA
Common Stock
2026-03-18 Sell 2,268 $117.56 266,626
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-27 Buy 4,000 $125.00 500,000
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-27 Buy 2,400 $125.00 300,000
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-18 Option exercise 2,148 $0.00
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-18 Sell 3,026 $79.16 239,538
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-18 Option exercise 2,148 $9.08 19,504
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-18 Option exercise 2,154 $7.14 15,380
Palvella Therapeutics Inc PVLA
Common Stock
2026-02-18 Sell 1,276 $79.97 102,042
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-18 Option exercise 2,154 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 38,517 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 124,603 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 44,123 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 48,956 $0.00
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
2026-02-05 Grant 64,318 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com